|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.12 SGD | +50.00% |
|
+50.00% | +22.45% |
| Apr. 15 | Pharmesis’ Attributable Loss for 2023 Widens | MT |
| Apr. 15 | Pharmesis International Ltd. Announces the Retirement of Ms. Lin Yimin as a Director | CI |
Pharmesis International Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 27.7 million compared to CNY 18.77 million a year ago. Net loss was CNY 1.04 million compared to CNY 3.05 million a year ago.
Basic loss per share from continuing operations was CNY 0.041 compared to CNY 0.133 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.45% | 2.43M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PHARMESIS INTERNATIONAL LTD. 
